Melissa Carpenter, PhD

Regulatory

Dr. Carpenter received a Ph.D. in the Laboratory of Cellular and Molecular Neurobiology, University of California, Irvine and is Principal at Carpenter Consulting Group. For the last 15 years, she has worked on the development of cell therapies using human adult and embryonic stem cells, in academia and industry.


Mason “Skip” Irving, III

Strategic Planning

Skip has spent more than 35 years advising companies on business strategy, technology commercialization, R&D planning, and mergers and acquisitions in the biotech, pharmaceutical and medical products industry.


David J. Kappos

Intellectual Property Strategy

David J. Kappos is a partner at Cravath, Swaine & Moore LLP.  He is widely recognized as one of the world’s foremost leaders in the field of intellectual property, including intellectual property management and strategy.


Gerald Klein, M.D.

Medical Affairs

Gerald L. Klein, MD, is acting Chief Medical Officer at ArunA Biomedical Inc. He is an expert in Medical Affairs and Clinical Development and has published numerous scientific papers.